We are live on ! Find out more
PCSA icon

Processa Pharmaceuticals
PCSA

10 hedge funds and large institutions have $448K invested in Processa Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership: →

more funds holding

Funds holding: →

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$193K
2
+$117K
3
+$26.2K
4
Citigroup
Citigroup
New York
+$38

Top Sellers

1
-$86.9K
2
-$56K
3
-$27.6K
4
TRCT
Tower Research Capital (TRC)
New York
-$1.29K
5
Bank of America
Bank of America
North Carolina
-$52
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
1
Connective Capital Management
California
$179K
SCM
2
Stonepine Capital Management
Oregon
$139K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$62.8K
VCM
4
Vanguard Capital Management
Pennsylvania
$32.1K
VFT
5
Vanguard Fiduciary Trust
Pennsylvania
$27.4K
UBS Group
6
UBS Group
Switzerland
$6.39K
TRCT
7
Tower Research Capital (TRC)
New York
$2.32K
Citigroup
8
Citigroup
New York
$35
Jones Financial Companies
9
Jones Financial Companies
Missouri
$17
Wells Fargo
10
Wells Fargo
California
$15
Jane Street
11
Jane Street
New York
–
HF
12
HRT Financial
New York
–
Bank of America
13
Bank of America
North Carolina
–